Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Mark E. Stearns

Drexel University College of Medicine

Dept. of Pathology

MS 435

245 N. Broad St.

USA

Name/email consistency: high

Drexel University College of Medicine, Dept. of Pathology, MS 435, 245 N. Broad St., USA. 2010
Department of Pathology, College of Medicine, Drexel University, MS 435, USA. 2004
Department of Pathology and Laboratory, Drexel University College of Medicine, 15th and Vine Sts, Philadelphia, USA. 2003

Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice. Stearns, M.E., Amatangelo, M.D., Varma, D., Sell, C., Goodyear, S.M. Am. J. Pathol. (2010) [Pubmed]
Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells. Stearns, M.E., Kim, G., Garcia, F., Wang, M. Mol. Cancer Res. (2004) [Pubmed]
IL-10 signaling via IL-10E1 is dependent on tyrosine phosphorylation in the IL-10R alpha chain in human primary prostate cancer cell lines. Stearns, M.E., Hu, Y., Wang, M. Oncogene (2003) [Pubmed]
Interleukin-10 activation of the interleukin-10E1 pathway and tissue inhibitor of metalloproteinase-1 expression is enhanced by proteasome inhibitors in primary prostate tumor lines. Stearns, M.E., Wang, M., Hu, Y., Garcia, F.U. Mol. Cancer Res. (2003) [Pubmed]